Trial
NCT06977568
A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pacira Pharmaceuticals, Inc
Collaborators
—
Condition
Osteoarthritis of Hip
Intervention
Zilretta
Why stopped
Study was stopped due to business decision and lack of enrollment. There were no safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-22